Friday, November 3, 2017

ABUS Is Abuzz...

Shares of Arbutus Biopharma Corp. (ABUS) have gained an impressive 122% year-to-date, thanks to rising investor optimism about the Company's pipeline. Also, let's take a look at few other pharma stocks that grabbed headlines this week.

from RTT - Biotech http://ift.tt/2yqau5R
via IFTTT

No comments:

Post a Comment